<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="29369">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02724371</url>
  </required_header>
  <id_info>
    <org_study_id>MEN-15-001</org_study_id>
    <nct_id>NCT02724371</nct_id>
  </id_info>
  <brief_title>A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction</brief_title>
  <acronym>Athena</acronym>
  <official_title>A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mentor Worldwide, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mentor Worldwide, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the safety and effectiveness with the Mentor MemoryGel® Larger Size
      Ultra High Profile (UHP-L) Breast Implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects, whose body shape is suited to a larger size implant than are currently available,
      will have their breasts reconstructed using the UHP-L Breast Implants either for the first
      time after a full mastectomy or as a revision of a previous breast reconstruction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 1, 2016</start_date>
  <completion_date type="Anticipated">September 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Any Reoperation</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Baker III, IV Capsular Contracture</measure>
    <time_frame>10 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Infection</measure>
    <time_frame>10 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Explantation with or without replacement</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Breast Reconstruction, Revision Breast Reconstruction</condition>
  <arm_group>
    <arm_group_label>Primary Breast Reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who meet the requirements for primary breast reconstruction (have not had previous silicone or saline breast implants, not including tissue expanders) and have been implanted with Mentor Larger Size MemoryGel Ultra High Profile Breast implants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Revision Breast Reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants who meet the requirements for revision breast reconstruction (have had previous silicone or saline breast implants) and have been implanted with Mentor Larger Size MemoryGel Ultra High Profile Breast implants</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mentor Larger Size MemoryGel Ultra High Profile Breast Implant</intervention_name>
    <description>The Mentor smooth and Siltex® larger size MemoryGel® Ultra High Profile (UHP-L) breast implants are large round silicone gel-filled breast implants. The devices are made with cross linked layers of silicone to provide the prosthesis with elasticity and integrity.</description>
    <arm_group_label>Primary Breast Reconstruction</arm_group_label>
    <arm_group_label>Revision Breast Reconstruction</arm_group_label>
    <other_name>UHP-L Breast Implant</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is female and is at least 18 years old

          -  A candidate for:

          -  Primary breast reconstruction in women at least 18 years old with surgically absent
             breast tissue (two-stage reconstruction [tissue expanders utilized with or without
             the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD®
             PLIABLE, utilized in a prior surgery to expand tissue for study device placement] to
             replace breast tissue post-mastectomy)

          -  Revision surgery in women at least 18 years old with surgically absent breast tissue
             (previous reconstruction with silicone-filled or saline-filled implants or revision
             reconstruction requiring expansion surgery prior to surgery for study device
             implantation, with or without the use of human acellular dermal matrices (ADM),
             limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand
             tissue for study device placement)

          -  Subject understands and signs the Informed Consent

          -  Subject agrees to return device to Mentor if device is explanted

          -  Subject agrees to comply with follow-up procedures, including returning for all
             follow-up visits

          -  Physician determines implant volume appropriate for the patient taking into account
             the subject's BMI and chest width

        Exclusion Criteria:

          -  Subject is pregnant at time of enrollment

          -  Subject is a current smoker, or has smoked within 3 months prior to enrollment, or
             plans to resume smoking within 3 months post-enrollment

          -  Currently has uncontrolled diabetes (at time of screening or enrollment)

          -  Has nursed a child within 3 months of study enrollment

          -  Confirmed or suspected diagnosis of the following rheumatological autoimmune diseases
             or immune compromised status: SLE, Sjogren's syndrome, scleroderma, polymyositis, or
             any connective tissue disorder, rheumatoid arthritis, crystalline arthritis,
             infectious arthritis, spondyloarthropathies, any other inflammatory arthritis,
             fibromyalgia, or chronic fatigue syndrome

          -  Currently has a condition that could compromise or complicate wound healing. Note,
             obesity alone is not an exclusion. All surgical risk factors (obesity, diabetes,
             smoking history, and prior radiation) should be considered in totality for proper
             subject selection

          -  Infection or abscess anywhere in the body

          -  Demonstrates tissue characteristics that are clinically incompatible with successful
             use of a breast implant (e.g. inadequate tissue or compromised vascularity)

          -  Possesses any condition, or is under treatment for any condition which, in the
             opinion of the investigator and/or consulting physicians(s), may constitute an
             unwarranted surgical risk

          -  Anatomic or physiologic abnormality that could lead to significant postoperative
             adverse events

          -  Demonstrates characteristics that are unrealistic/unreasonable with the risks
             involved with the surgical procedure

          -  Untreated active, or inappropriately/inadequately treated breast malignancy, without
             surgical treatment

          -  Anticipated need for use of ADM/mesh at the time of implant or implant exchange

          -  Subject is HIV positive

          -  Works for Mentor or the study doctor or is directly related to anyone who works for
             Mentor or the study doctor

          -  Implanted metal or metal devices that make a MRI scan prohibitive, history of
             claustrophobia or other condition that would make a MRI scan prohibitive
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Canady, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mentor Worldwide, LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Schut</last_name>
    <phone>949-923-4135</phone>
    <email>athena_clinical@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Plastic Surgery Associates of Montgomery</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Mozingo</last_name>
      <phone>334-430-1380</phone>
    </contact>
    <investigator>
      <last_name>Michael Bentley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Arizona - Scottsdale/Phoenix (MCSB)</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Ryan</last_name>
      <phone>480-342-1208</phone>
      <email>ryan.debra29@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Alanna Rebecca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Andres Plastic Surgery</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronica Childers</last_name>
      <phone>480-752-7874</phone>
      <email>surgeryscheduling@aaaaplasticsurgery.com</email>
    </contact>
    <investigator>
      <last_name>Lewis Andres</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Susan E Downey MD, Inc</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irma Corral</last_name>
      <phone>323-468-0127</phone>
    </contact>
    <investigator>
      <last_name>Susan E Downey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liu Plastic Surgery</name>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <zip>95032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Gough</last_name>
      <phone>408-418-0808</phone>
      <email>michelle@liuplasticsurgery.com</email>
    </contact>
    <investigator>
      <last_name>Jerome Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Meyer</last_name>
      <phone>650-724-1953</phone>
      <email>smeyer27@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Geoffrey Gurtner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgia Institute of Plastic Surgery</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teri Goolsby</last_name>
      <phone>912-355-8000</phone>
    </contact>
    <investigator>
      <last_name>Richard Greco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Goshen General Hospital</name>
      <address>
        <city>Goshen</city>
        <state>Indiana</state>
        <zip>46526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kellee Hedges</last_name>
      <phone>574-968-9100</phone>
      <email>kelleeh@thecentrepc.com</email>
    </contact>
    <investigator>
      <last_name>Ronald Downs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kellee Hedges</last_name>
      <phone>574-968-9100</phone>
      <email>kelleeh@thecentrepc.com</email>
    </contact>
    <investigator>
      <last_name>Ronald Downs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Prasnicki</last_name>
      <phone>952-925-1111</phone>
      <email>rprasnicki@mmkplasticsurgery.com</email>
    </contact>
    <investigator>
      <last_name>Mark Migliori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Plastic Surgery Group PC</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tara Lee</last_name>
      <phone>423-763-4571</phone>
      <email>Tara.Lee@thepsg.org</email>
    </contact>
    <investigator>
      <last_name>Mark Brzezienski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcia Spear</last_name>
      <phone>615-343-8426</phone>
      <email>marcia.spear@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Stephane Braun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackye Costello</last_name>
      <phone>713-441-3246</phone>
    </contact>
    <investigator>
      <last_name>Jeffrey Friedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Castello</last_name>
      <phone>713-441-3246</phone>
      <email>jcastello@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Friedman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 4, 2017</lastchanged_date>
  <firstreceived_date>March 21, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
